Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies

https://www.globenewswire.com/news-release/2021/11/11/2332692/0/en/Zealand-Pharma-Presents-Financial-Results-for-the-First-Nine-Months-of-2021-Provides-Updates-on-Commercial-Launch-and-Timing-for-Congenital-Hyperinsulinism-and-Short-Bowel-Syndrome.html

press release